【】Ruxolitinib cream,a novel JAK inhibitor,blocks the JAK/STAT pathway key to vitiligo pathogenesis.It shows promise for treating vitiligo.Combining with phototherapy,microneedling,or oral JAK inhibitors enhances outcomes.This review covers ruxolitinib"s mechanism,safety,latest advances in vitiligo,and the feasibility of its combination therapies.